Eye Diseases

237 trials 74 recruiting

Filter these 237 trials by phase, country and sponsor.

Open in Search →

SEER-3: A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of… Ended

2022-502697-16-00 Neurotrophic Keratopathy 5 2023-08-29
A study to test how well different doses of BI 1584862 are tolerated by healthy men Ended

2023-503541-54-00 Healthy volunteer trial 3 2023-08-28
A study to evaluate Intravitreal JNJ-81201887(AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary… Ended

2022-500746-16-00 Geographic Atrophy 4 2023-08-11
A Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) in Subjects with Fuchs Dystrophy Ended

2022-502643-35-00 Fuchs Endothelial Corneal Dystrophy 5 2023-08-09
A study in healthy men to test how itraconazole influences the amount of BI 1815368 in the blood Ended

2023-503783-16-00 Healthy 3 2023-08-02
MyKid-study: a study to examine the effect and safety of an injection of Mydrane® into the eye of children who will undergo cataract surgery Ended

2023-504173-21-00 pediatric cataract 6 2023-07-01
A STUDY TO INVESTIGATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF RO7200220 ADMINISTERED INTRAVITREALLY IN PATIENTS WIT… Ended

2022-501794-39-00 Uveitic Macular Edema 5 2023-06-28
A study to test how well different doses of BI 1815368 are tolerated by healthy men Ended

2023-503815-13-00 Healthy 3 2023-06-19
Faricimab for high-frequent Aflibercept treated Neovascular age-related macular degeneration: a monocenter, randomized, double-masked compar… Ended

2024-515377-10-00 Neovascular age-related macular degeneration 11 2023-06-12
Phase 3 Study to Assess Batoclimab in Participants with Active Thyroid Eye Disease Ended

2024-512649-18-00 Thyroid Eye Disease 5 2023-06-05
MULTICENTRE, RANDOMISED, DOUBLE-BLIND, VEHICLE AND ACTIVE-CONTROLLED PHASE III STUDY EVALUATING THE EFFICACY AND SAFETY OF KETOTIFEN OPHTHAL… Ended

2023-503185-23-00 SEASONAL ALLERGIC CONJUNCTIVITIS 5 2023-05-31
A Study to Investigate the Safety and Effectiveness of Ripasudil (K-321) Eye Drops After Descemetorhexis in Subjects with Fuchs Endothelial … Ended

2024-511752-40-00 Fuchs Endothelial Corneal Dystrophy 5 2023-05-05
A Study to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of RO7200220 Administered Intravitreally in Patients wit… Ended

2022-501793-19-00 Uveitic Macular Edema 5 2023-04-21
Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma Ended

2024-511254-51-00 Glaucoma 1 2023-02-09
Clinical Trial To Determine The Efficacy And Safety Of Insulin Eye Drops In Dry Eye In Patients With Topical Hypotensors Ended

2024-518407-22-00 Dry eye disease 6 2023-02-08
Phase 2b Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis Ended

2024-514975-16-00 Non-infectious, Intermediate-, Posterior- or Pan-uveiti 4 2022-12-22
An Open-Label Extension Study for Patients who Previously Completed Study ISEE2008 (GATHER2) Ended

2024-515185-13-00 geographic atrophy 5 2022-12-21
Phase 3 Study of Tinlarebant in the Treatment in Adolescent Stargardt Subjects Ended

2024-513483-26-00 Stargardt Disease 5 2022-11-28
Study to Evaluate the Safety and Efficacy of Linsitinib in Patients with Active, Moderate to Severe Thyroid Eye Disease Ended

2024-514449-12-00 Disease (TED) 4 2022-11-04
A multiple ascending dose (MAD) safety, tolerability and efficacy study of VRDN-001, a humanized monoclonal antibody directed against the IG… Ended

2024-512244-36-00 Thyroid eye disease (TED) 10 2022-10-25
Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye Ended

2024-518376-31-00 Dry eye disease 6 2022-10-19
Molecular imaging exploration of ocular angiogenic activity and evaluation of its value in therapeutic follow-up of AMD patients Ended

2024-516970-31-00 Age-related macular degeneration 4 2022-10-02
A randomized, double-blind, placebo-controlled dose-finding study of 0.05%, 0.025%, 0.01% and 0.005% atropine eye drops to inhibit myopia pr… Ended

2024-516758-23-00 Myopia progression in children 4 2022-09-19
Early Reperfusion Therapy for Recovery of Vision in Acute Central Retinal Artery Occlusion Ended

2023-507388-21-00 Acute non-arteritic central retinal artery occlusion (C 5 2022-09-08